Surgery Partners Inc (SGRY)

NASD · Healthcare · Medical Care Facilities · USA

Surgery Partners Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Care Facilities industry.

Surgery Partners runs a collection of surgical and medical treatment facilities throughout the United States, comprising ambulatory surgery centers, short-stay hospitals, and physician practices across multiple specialties. The company delivers non-emergency surgical procedures in fields such as orthopedics, ophthalmology, and gastroenterology. Its facilities generate revenue through service fees and receive reimbursement from government programs and private insurance sources.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Surgery Partners Inc stock.

Our verdict on SGRY

Undervalued: intrinsic value $43.29 per share, market price $26.85, margin of safety 38.0% (as of 2026-11-17).

Discounting its cash flows at 9.1% (average of 2 methods) values the shares at $43.29; the price of $26.85 is 38% below that value, and 76% of that value comes from beyond year five.

ETFs with the most weight in SGRY

17 more funds hold it; the full list is part of the paid plan.

More on SGRY

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than SGRY in Medical Care Facilities

3 more in this industry show a wider margin of safety.

Is SGRY undervalued or overvalued?

SGRY is undervalued (as of the 2026-11-17 close). Discounting its cash flows at 9.1% (average of 2 methods) values the shares at $43.29; the price of $26.85 is 38% below that value, and 76% of that value comes from beyond year five.

What is the intrinsic value of SGRY?

$43.29 per share (as of the 2026-11-17 close), against a market price of $26.85. That is a margin of safety of 38.0%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.